Atorvastatin/Ramipril/Aspirin

阿托伐他汀/雷米普利/阿司匹林

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtorvastatin/Ramipril/Aspirin

Drug Alias Name乙酰水杨酸/雷米普利/阿托伐他汀Acetylsalicylic Acid/Atorvastatin/RamiprilAspirin/Ramipril/Atorvastatin阿司匹林/阿托伐他汀/雷米普利Aspirin/Atorvastatin/Ramipril +[10]

ClassificationSmall molecules

Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitorsAngiotensin-converting enzyme inhibitors

TargetsAngiotensin-converting enzymeHMG-CoA reductaseCyclooxygenases

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsCardiovascular Diseases

Approved Indications in ChinaN/A

Original Approved Country/TerritorySpain

Original Approved Date2013/12/17

Country/TerritorySpain

CombinationsYes Ramipril Aspirin Atorvastatin Calcium Hydrate

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesFerrer

China Registration ClassN/A

Develop Information

Active CompaniesFerrer

Inactive CompaniesN/A

Active IndicationsCardiovascular Diseases

Inactive IndicationsN/A

Other Information

ATC CodeC10BX